These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15830122)

  • 1. Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia.
    Fujita Y; Ezura Y; Bujo H; Nakajima T; Takahashi K; Kamimura K; Iino Y; Katayama Y; Saito Y; Emi M
    J Hum Genet; 2005; 50(4):203-209. PubMed ID: 15830122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association of low-density lipoprotein receptor-related protein 2 (LRP2) with plasma lipid levels.
    Mii A; Nakajima T; Fujita Y; Iino Y; Kamimura K; Bujo H; Saito Y; Emi M; Katayama Y
    J Atheroscler Thromb; 2007 Dec; 14(6):310-6. PubMed ID: 18174661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A promoter SNP (-1323T>C) in G-substrate gene (GSBS) correlates with hypercholesterolemia.
    Ono S; Ezura Y; Emi M; Fujita Y; Takada D; Sato K; Ishigami T; Umemura S; Takahashi K; Kamimura K; Bujo H; Saito Y
    J Hum Genet; 2003; 48(9):447-450. PubMed ID: 12955585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercholesterolemia associated with splice-junction variation of inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) gene.
    Fujita Y; Ezura Y; Emi M; Sato K; Takada D; Iino Y; Katayama Y; Takahashi K; Kamimura K; Bujo H; Saito Y
    J Hum Genet; 2004; 49(1):24-28. PubMed ID: 14661079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
    Cerda A; Genvigir FD; Arazi SS; Hirata MH; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
    Clin Chim Acta; 2010 May; 411(9-10):631-7. PubMed ID: 20064494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
    J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic study of statin therapy and cholesterol reduction.
    Chasman DI; Posada D; Subrahmanyan L; Cook NR; Stanton VP; Ridker PM
    JAMA; 2004 Jun; 291(23):2821-7. PubMed ID: 15199031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a GFOD2 variant on responses in total and LDL cholesterol in Mexican subjects with hypercholesterolemia after soy protein and soluble fiber supplementation.
    Guevara-Cruz M; Lai CQ; Richardson K; Parnell LD; Lee YC; Tovar AR; Ordovás JM; Torres N
    Gene; 2013 Dec; 532(2):211-5. PubMed ID: 24064143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of apolipoprotein A-I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levels.
    Larson IA; Ordovas JM; Barnard JR; Hoffmann MM; Feussner G; Lamon-Fava S; Schaefer EJ
    Clin Genet; 2002 Mar; 61(3):176-84. PubMed ID: 12000358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of non-synonymous obesity risk alleles in SH2B1 (rs7498665) and APOB48R (rs180743) in obese children and adolescents undergoing a 1-year lifestyle intervention.
    Volckmar AL; Pütter C; Song JY; Graniger J; Knoll N; Wolters B; Hebebrand J; Scherag A; Reinehr T; Hinney A
    Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):334-7. PubMed ID: 23519644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals.
    Sorkin SC; Forestiero FJ; Hirata MH; Guzmán EC; Cavalli SA; Bertolami MC; Salazar LA; Hirata RD
    Clin Chem Lab Med; 2005; 43(12):1339-45. PubMed ID: 16309370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A minor allele of the haplotype located in the 19q13 loci is associated with a decreased risk of hyper-LDL-cholesterolemia, and a balanced diet and high protein intake can reduce the risk.
    Park S; Kang S
    Lipids Health Dis; 2020 Jul; 19(1):178. PubMed ID: 32727492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANGPTL3 serum concentration and rare genetic variants in Finnish population.
    Tikka A; Metso J; Jauhiainen M
    Scand J Clin Lab Invest; 2017 Dec; 77(8):601-609. PubMed ID: 28972399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women.
    Ezura Y; Nakajima T; Urano T; Sudo Y; Kajita M; Yoshida H; Suzuki T; Hosoi T; Inoue S; Shiraki M; Emi M
    Bone; 2007 Apr; 40(4):997-1005. PubMed ID: 17306638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.
    Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.
    Skogsberg J; McMahon AD; Karpe F; Hamsten A; Packard CJ; Ehrenborg E;
    J Intern Med; 2003 Dec; 254(6):597-604. PubMed ID: 14641801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia.
    Kajinami K; Brousseau ME; Ordovas JM; Schaefer EJ
    Am J Cardiol; 2004 Jan; 93(1):104-7. PubMed ID: 14697480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.